ClinicalTrials.gov record

Completed Not applicable Interventional Accepts healthy volunteers Results available

To Show the Safety and Effectiveness of the Demetech Barbed Polydioxanone (PDO) Suture

ClinicalTrials.gov ID: NCT06404372

Public ClinicalTrials.gov record NCT06404372. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Oct 22, 2026, 3:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Pivotal, Blinded Multi-Center Study to Show the Safety and Effectiveness of the Demetech Barbed PDO Suture

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The clinical trial, sponsored by Sutura Medical Technology, Inc., is a pivotal, blinded, multi-center study assessing the safety and effectiveness of the Demetech Barbed PDO Suture, an absorbable Polydioxanone suture, for the temporary treatment of midface wrinkles. The trial will enroll 57 subjects across up to four sites, following them over a 12-month period to evaluate improvements in wrinkles based on the Lemperle Classification Facial Wrinkle Scale. Primary endpoints include assessing the rate of adverse events and a significant reduction in wrinkle severity at 6 months, with secondary endpoints focusing on longer-term results and patient satisfaction.

Study identification

NCT ID: NCT06404372
Recruitment status: Completed
Study type: Interventional
Phase: Not applicable
Lead sponsor: Sutura Medical Technology LLC; Industry
Enrollment: 57 participants

Conditions and interventions

Conditions

Wrinkle

Interventions

Demetech Barbed PDO Suture Device

Device

Eligibility (public fields only)

Age range: 22 Years and older
Sex: All
Healthy volunteers: Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 18, 2022 (Actual)
Primary completion: Dec 4, 2023 (Actual)
Completion: Jul 30, 2024 (Actual)
Last update posted: Aug 11, 2026

2022 – 2024

United States locations

U.S. sites: 4
U.S. states: 3
U.S. cities: 4

Facility	City	State	ZIP	Site status
Rejuva Medical Aesthetics	Los Angeles	California	90025	—
Cosmetic Injectables Center	Sherman Oaks	California	91423	—
Vedas Med Spa	The Woodlands	Texas	77381	—
Dr. Kristin Tarbet Facial Plastic Surgery	Bellevue	Washington	98004	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06404372, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Aug 11, 2026 · Synced Oct 22, 2026

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06404372 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →